Based on the ChIP-seq data of NFκB-p65 in multiple cancer cells and samples from the Cistrome database and subsequent verification experiments, we guessed and acknowledged that SFE could block the transcription-promoting activity of the NFκB pathway to suppress ESCC development. The gene discussed is NFKB1; the disease is esophageal squamous cell carcinoma.